Search research articles
Contact Us
Filters
Showing results (21-30 of 662) with videos related to
Page
of 67
Sort By:
Trends in Immunology
|
May 18, 2017
Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed
Satish K Pillai, Steven G Deeks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2012
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
Rajesh T Gandhi, Steven G Deeks
Science Translational Medicine
|
July 15, 2011
Drug effectiveness explained: the mathematics of antiviral agents for HIV
Alan S Perelson, Steven G Deeks
Current Opinion in HIV and AIDS
|
April 18, 2009
Partial treatment interruptions
Steven G Deeks, Jeffrey N Martin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2009
CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts
Elvin H Geng, Steven G Deeks
Immunity
|
January 19, 2017
Mucosal Microbes Mitigate Maladies
Ivan Vujkovic-Cvijin, Steven G Deeks
Nature
|
July 20, 2012
Public health: Towards a cure for HIV
Steven G Deeks, Françoise Barré-Sinoussi
Science (New York, N.Y.)
|
July 12, 2014
Immunologic strategies for HIV-1 remission and eradication
Dan H Barouch, Steven G Deeks
The Journal of Clinical Investigation
|
April 7, 2004
The immune response to AIDS virus infection: good, bad, or both?
Steven G Deeks, Bruce D Walker
The Journal of Clinical Investigation
|
April 28, 2020
The immune response fails to control HIV early in initial virus spread
Lillian B Cohn, Steven G Deeks
Page
of 67
Search research articles
Search
Showing results (21-30 of 662) with videos related to
Sort By:
Page
of 67
Trends in Immunology
|
May 18, 2017
Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed
Satish K Pillai, Steven G Deeks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2012
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
Rajesh T Gandhi, Steven G Deeks
Science Translational Medicine
|
July 15, 2011
Drug effectiveness explained: the mathematics of antiviral agents for HIV
Alan S Perelson, Steven G Deeks
Current Opinion in HIV and AIDS
|
April 18, 2009
Partial treatment interruptions
Steven G Deeks, Jeffrey N Martin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2009
CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts
Elvin H Geng, Steven G Deeks
Immunity
|
January 19, 2017
Mucosal Microbes Mitigate Maladies
Ivan Vujkovic-Cvijin, Steven G Deeks
Nature
|
July 20, 2012
Public health: Towards a cure for HIV
Steven G Deeks, Françoise Barré-Sinoussi
Science (New York, N.Y.)
|
July 12, 2014
Immunologic strategies for HIV-1 remission and eradication
Dan H Barouch, Steven G Deeks
The Journal of Clinical Investigation
|
April 7, 2004
The immune response to AIDS virus infection: good, bad, or both?
Steven G Deeks, Bruce D Walker
The Journal of Clinical Investigation
|
April 28, 2020
The immune response fails to control HIV early in initial virus spread
Lillian B Cohn, Steven G Deeks
Page
of 67